Trends in mortality and causes of death among women with HIV in the United States: A 10-year study

Journal of Acquired Immune Deficiency Syndromes

Volumn 51, Issue 4, 2009, Pages 399-406

  French, Audrey L ^a,h   Gawel, Susan H ^b   Hershow, Ronald ^b   Benning, Lorie ^c   Hessol, Nancy A ^d   Levine, Alexandra M ^e   Anastos, Kathryn ^f   Augenbraun, Michael ^g   Cohen, Mardge H ^a  

^a RUSH UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e City of Hope Medical Center   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

^h Jr Hospital of Cook County   (United States)

Author keywords

HIV; Mortality; Non AIDS mortality; Viral hepatitis; Women

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DEATH CERTIFICATE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MORTALITY; OBESITY; PRIORITY JOURNAL; UNITED STATES;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES;

EID: 68049131269     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181acb4e5     Document Type: Article

References (42)

1. Palella FJ, Delaney KM, Moorman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860. (Pubitemid 28135961)
2. Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002;113:91-98. (Pubitemid 34804744)
3. MMWR. Age-adjusted death rates for human immunodeficiency virus (HIV) infection by sex-United States, 1987-2003. Mortality and Morbidity Weekly Report. 2005;46:1188.
4. Keiser O, Taffe P, Zwahlen M, et al. All cause mortality in the Swiss HIV cohort study from 1990 to 2001 in comparison with the Swiss population. AIDS. 2004;18:1835-1843.
5. Levine RS, Briggs NC, Kilbourne BS, et al. Black-white mortality from HIV in the United States before and after the introduction of highly active antiretroviral therapy in 1996. Am J Public Health. 2007;97:1884-1892.
6. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. Epidemiology. 1998;9:117-125.
7. Hessol NA, Schneider M, Greenblatt RM, et al. Retention of women enrolled in a prospective study of HIV infection: impact of race, unstable housing and use of HIV therapy. Am J Epidemiol. 2001;154:563-573.
8. National Center for Health Statistics compressed mortality file on CDC wonder. Available at: http://wonder.cdc.gov/wonder/help/cmf.html. Accessed June 29, 2008.
9. Moyes S, Nieto FJ. Epidemiology: Beyond the Basics. 2nd ed. Boston: Jones and Barlett Publishers; 2006.
10. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Available at: http://aidsinfo.nih.gov/Guidelines/Default.aspx. Accessed March 18, 2009.
11. Lewden C, Salmon D, Morlat P, et al. Causes of death among HIV-infected adults in the era of potent antiretroviral therapy; emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34:121-130. (Pubitemid 40347381)
12. Smit C, Geskus R, Walker S, et al, and CASCADE Collaboration. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS. 2006;20:741-749.
13. Weber R, Sabin CA, Friis-Moller N, et al. The Data Collection on Adverse Events of Anti-HIV Drugs Study Group. Liver-related deaths in persons infected with the human immunodeficiency virus. Arch Intern Med. 2006; 166:1632-1641.
14. Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27-34. (Pubitemid 44306484)
15. Kohli R, Lo Y, Howard AA, et al. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;41:864-872. (Pubitemid 41266755)
16. Poundstone KE, Chaisson RE, Moore RD. Differences in HIV disease progression in injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS. 2001;15:1115-1123. (Pubitemid 32549862)
17. Sackoff JE, Hanna DB, Pfeiffer MR, et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397-406. (Pubitemid 46768570)
18. Reif S, Whetten K, Thielman N. Association of race and gender with use of antiretroviral therapy among HIV-infected individual in the southeastern United States. South Med J. 2007;100:775-781. (Pubitemid 47356877)
19. Eisenmann D, Bogart LM, Bird CE, et al. Differential diffusion of HIV technologies by gender; the case of highly active antiretroviral therapy. AIDS Patient Care STDS. 2007;21:390-399.
20. Cohen MH, Cook JA, Grey D, et al. Medically eligible women who do not use HAART: the importance of abuse, drug use and race. Am J Public Health. 2004;94:1133-1140. (Pubitemid 38857315)
21. Hessol NA, Kalinowski A, Benning L, et al. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Clin Infect Dis. 2007;44:28. (Pubitemid 46079997)
22. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005;6:99-106.
23. Cohen M, Deamant C, Barkan S, et al. Domestic violence and childhood sexual abuse in women with HIV infection and women at risk for HIV. Am J Public Health. 2000;90:560-565. (Pubitemid 30167416)
24. Wang C, Vlahov D, Galai N, et al. The effect of HIV infection on overdose mortality. AIDS. 2005;19:935-942. (Pubitemid 40834936)
25. Emery S, Neuhaus J, Phillips A, et al. Major clinical outcomes in patients not treated with antiretroviral therapy at baseline in SMART; rationale for a trial to examine early treatment of HIV disease. Presented at: 4th International AIDS Society Conference; July 22-25, 2007; Sydney, Australia.
26. Kessler RC, McGonagle KA, Swartz M, et al. Sex and depression in the National Comorbidity Survery: lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993;29:85-96. (Pubitemid 23334116)
27. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94:1133-1140. (Pubitemid 38857313)
28. Sambamoorthi U, Walkup J, Offson M, et al. Antidepressant treatment and health services utilization among HIV-infected Medicaid patients diagnosed with depression. J Gen Intern Med. 2000;5:344-345. (Pubitemid 30333828)
29. Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection. JAMA. 1993;270: 2563-2567. (Pubitemid 23346694)
30. Shor-Posner G, Campa A, Zhang G, et al. When obesity is desirable: a longitudinal study of the Miami HIV-1 infected drug abusers (MIDAS) Cohort. J Acquir Immune Defic Syndr. 2000;23:81-88. (Pubitemid 30123269)
31. Jones CY, Hogan JW, Snyder B, et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations of HIV disease progression and changes in body mass index in women in the HIV Epidemiology Research Study cohort. Clin Infect Dis. 2003;37: S69-S80. (Pubitemid 37102727)
32. Amorosa V, Synnestvedt M, Gross R, et al. A tale of two epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr. 2005;39:557-561. (Pubitemid 41098470)
33. O'Rourke RW, Kay T, Scholz MH, et al. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg. 2005;15:1463-1468. (Pubitemid 41746423)
34. Womack J, Tien PC, Feldman J, et al. Obesity and immune cell counts in women. Metabolism. 2007;56:998-1004. (Pubitemid 46890984)
35. Marin B, Thiebaut R, Rondeau V, et al. Relationships between markers of immunodeficiency and non-AIDS related cause of death in the cART era, CASCADE Study Group. Presented at: 4th International AIDS Society Conference; July 22-25, 2007; Sydney, Australia.
36. Greub G, Lederberger B, Battegay M, et al. Clinical progression, survival and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis co-infection. Lancet. 2000;356:1800-1805.
37. McCormick A. Trends in mortality statistics in England and Wales with particular reference to AIDS from 1984 to April 1987. Br Med J. 1988; 296:1289-1292.
38. Hessol NA, Buchbinder SP, Colbert, et al. Impact of HIV infection on mortality and accuracy of AIDS reporting on death certificates. Am J Public Health. 1992;82:561-564.
39. Stellman MJ. Accuracy of death certificate completion: the need for formalized physician training. JAMA. 1996;275:794-796.
40. Breslau N. Depressive symptoms, major depression and generalized anxiety: a comparison of self-reports on CES-D and results from diagnostic interviews. Psychiatry Res. 1985;6:71-74. (Pubitemid 15042334)
41. Low-Beer S, Chan K, Yip B, et al. Depressive symptoms decline among person on HIV protease inhibitors. J Acquir Immune Defic Syndr. 2000; 23:295-301. (Pubitemid 30327031)
42. Cook JA, Cohen MH, Burke J, et al. Effects of depressive symptoms and mental health quality on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr. 2002;30: 401-409. (Pubitemid 34857314)